AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
BIOCON PHARMA I
Drug class
Antifibrinolytics
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin. Read more about Antifibrinolytics
63 drugs in this class 56 manufacturers
Drugs in Antifibrinolytics
AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
NOVADOZ PHARMAC
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · HEMORRHAGING IN HEMOPHILIA ·+1
ARMAS PHARMACEU
AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
CIVICA, INC.
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · MENORRHAGIA
ADVAGEN PHARMA
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · HEMORRHAGING IN HEMOPHILIA ·+1
APOLLO/PROVEPHA
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · HEMORRHAGING IN HEMOPHILIA ·+1
AVENACY, INC
AMINOCAPROIC ACID
AMINOCAPROIC ACID · HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE ·+1
BLU PHARMACEUTI
TRANEXAMIC ACID
ANTIFIBRINOLYTICS · HEMORRHAGING IN HEMOPHILIA ·+1
PROVEPHARM-NOVA
Filter & compare in the drug finder →
Opens the drug finder with Antifibrinolytics preselected. Add indication or manufacturer filters there.
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin.
Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork.
By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenital or acquired bleeding disorders.
-
fda.gov
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork
-
nih.gov
Antifibrinolytics are a therapeutic class of hemostatic agents that prevent the breakdown of blood clots by inhibiting the enzymatic dissolution of fibrin Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in...
-
fda.gov
Primarily comprising synthetic lysine analogues such as tranexamic acid and aminocaproic acid, these medications bind to lysine receptor sites on plasminogen and plasmin, thereby preventing plasmin from binding to and degrading the fibrin meshwork By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenita...
-
nih.gov
By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenital or acquired bleeding disorders
-
nih.gov
By stabilizing hemostatic clots and reducing blood loss, antifibrinolytics are widely utilized in major surgical procedures, traumatic hemorrhage, heavy menstrual bleeding, postpartum hemorrhage, and perioperative management for patients with congenital or acquired bleeding disorders
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.